Alerts will be sent to your verified email
Verify EmailCOVIDH
|
iSERA Lifesciences
|
Cambridge Tech Enter
|
Hiliks Technologies
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.47 % | 7.29 % | 1.61 % |
|
5yr average Equity Multiplier
|
26.8 | 2.12 | 1.84 |
|
5yr Average Asset Turnover Ratio
|
1.36 | 0.89 | 0.44 |
|
5yr Avg Net Profit Margin
|
-10.35 % | -0.04 % | 3.25 % |
|
Price to Book
|
134.58 | 0.94 | 2.61 |
|
P/E
|
0.0 | 0.0 | 364.51 |
|
5yr Avg Cash Conversion Cycle
|
222.74 Days | 100.09 Days | 536.23 Days |
|
Inventory Days
|
0.0 | 0.0 | 0.0 |
|
Days Receivable
|
222.74 Days | 100.09 Days | 438.68 Days |
|
Days Payable
|
0.0 | 10.12 Days | -1314.6 Days |
|
5yr Average Interest Coverage Ratio
|
-13.96 | 6.57 | 8.5 |
|
5yr Avg ROCE
|
2.86 % | 3.04 % | 2.79 % |
|
5yr Avg Operating Profit Margin
|
2.66 % | 6.52 % | 8.53 % |
|
5 yr average Debt to Equity
|
14.12 | 0.69 | 0.01 |
|
5yr CAGR Net Profit
|
n/a | n/a | 16.98 % |
|
5yr Average Return on Assets
|
-18.53 % | -0.49 % | 1.03 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
58.63 % | 55.75 % | 4.65 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-41.37 % | 8.84 % | -5.19 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
iSERA Lifesciences
|
Cambridge Tech Enter
|
Hiliks Technologies
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|